akynzeo netupitant/palonosetron (as hydrochloride) 300 mg/500 mcg capsule blister pack
juniper biologics pty ltd - netupitant, quantity: 300 mg; palonosetron hydrochloride, quantity: 0.56 mg (equivalent: palonosetron, qty 0.5 mg) - capsule - excipient ingredients: microcrystalline cellulose; sucrose laurate; povidone; croscarmellose sodium; purified water; silicon dioxide; sodium stearylfumarate; magnesium stearate; glyceryl caprylate/caprate; glycerol; polyglyceryl-3 dioleate; butylated hydroxyanisole; nitrogen; gelatin; titanium dioxide; iron oxide yellow; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; sorbitol; 1,4-sorbitan; mannitol - akynzeo is indicated in adult patients for: prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
granisol tab/syr
intra lab - granisetron hcl. - tab/syr - 1mg/1mg
manisol 20% iv infusion
orion infusion ltd. - mannitol - iv infusion - 20 gm/100 ml
anisol liquid
jayson natural product ltd. (unani) - sharbat atfal - liquid
anisol 20% w.s.p
shennong animal health (malaysia) sdn. bhd. - levamisole hydrochloride -
atorvastatin
psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10 mg - film coated tablet - 10 mg - active: atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.
atorvastatin
psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20 mg - film coated tablet - 20 mg - active: atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.
atorvastatin
psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40 mg - film coated tablet - 40 mg - active: atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.
atorvastatin
psm healthcare ltd trading as api consumer brands - atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80 mg - film coated tablet - 80 mg - active: atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80 mg excipient: butylated hydroxyanisole colloidal silicon dioxide croscarmellose sodium sepifilm lp 010 magnesium stearate mannitol microcrystalline cellulose purified water sodium carbonate sodium laurilsulfate - indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. atorvastatin tablet is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.
ezetimibe-simvastatin sandoz tablet 1010mg
sandoz singapore pte. ltd. - ezetimibe; simvastatin (contains butylhydroxyanisole (bha) 0.01%) - tablet - ezetimibe 10.000mg; simvastatin (contains butylhydroxyanisole (bha) 0.01%) 10.000mg